US Stock MarketDetailed Quotes

OCGN Ocugen

Watchlist

1.2400
-0.0700-5.34%

Close Aug 16 16:00 ET

1.2600
+0.0200+1.61%

Post 20:02 ET

356.94MMarket Cap-6888P/E (TTM)

Ocugen Stock Forum

Trytosaveabit

Aug 12 14:09

Watching for data!

$Ocugen (OCGN.US)$ I expect to see data realeased for OCU410ST trial before the end of Q3

Trytosaveabit

Aug 5 05:34

Update

$Ocugen (OCGN.US)$ Reuters· 3 mins ago
Ocugen, Inc. Announces FDA Approval of Expanded Access Program for Patients With Retinitis Pigmentosa

104114357

Aug 1 06:54

$Ocugen (OCGN.US)$ what's happening here?

Trytosaveabit

Jul 25 05:50

Update

$Ocugen (OCGN.US)$ Ocugen Has Completed Dosing In Third Cohort Of Phase 1/2 ArMaDa Trial For OCU410 (AAV-hRORA) For Geographic Atrophy, The Company Has Initiated Phase 2 Trial To Assess OCU410 In Larger Group Of Patients

104534386

Jul 17 03:39

$Ocugen (OCGN.US)$ i regret not buying this share

porsh

Jul 15 08:19

$Ocugen (OCGN.US)$ yes slow and steady

hui3897

Jul 13 16:39

$Ocugen (OCGN.US)$ slow and steady

Trytosaveabit

Jun 21 06:00

Update

$Ocugen (OCGN.US)$ Reuters· just
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in Gardian Study for Stargardt Disease